An overview of morbidity associated with obstructive sleep-disordered breathing and indications for treatment Source: Annual Congress 2013 –PG19 Obstructive sleep-disordered breathing throughout childhood: diagnosis, associated morbidity and treatment Year: 2013
What are the treatment options for obstructive sleep-disordered breathing in childhood? Source: Annual Congress 2013 –PG19 Obstructive sleep-disordered breathing throughout childhood: diagnosis, associated morbidity and treatment Year: 2013
Long-term cardiovascular outcomes of patients with obstructive sleep apnoea not treated with nasal CPAP Source: Eur Respir J 2002; 20: Suppl. 38, 294s Year: 2002
Preoperative parameters predicting outcome of adenotonsillectomy for obstructive sleep-disordered breathing in children Source: Eur Respir J 2007; 30: Suppl. 51, 470s Year: 2007
Cardiovascular and metabolic effects of CPAP in obese obstructive sleep apnoea patients Source: Eur Respir J 2008; 31: 223-225 Year: 2008
Treatment by helium-oxygen mixture improves pulmonary hemodynamic in patients with obstructive sleep apnea Source: Eur Respir J 2002; 20: Suppl. 38, 295s Year: 2002
Treatment of obstructive sleep apnea improves cardiovascular outcome. A prospective study Source: Eur Respir J 2006; 28: Suppl. 50, 817s Year: 2006
Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012
Severity of sleep-disordered breathing is an independent predictor of metabolic dysfunction in a population with obstructive sleep apnoea Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011
Diet and exercise in the management of obstructive sleep apnoea and cardiovascular disease risk Source: Eur Respir Rev, 26 (144) 160110; 10.1183/16000617.0110-2016 Year: 2017
CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD Source: Eur Respir J 2010; 35: 132-137 Year: 2010
Effect of ventilation therapy on mortality rate among obesity hypoventilation syndrome and obstructive sleep apnoea patients Source: ERJ Open Res, 6 (2) 00101-2019; 10.1183/23120541.00101-2019 Year: 2020
Sleep-disordered breathing in the elderly Source: Eur Respir Mon; 2009: 43: 179–204 Year: 2009
Cardiovascular morbidity in obstructive sleep apnoea Source: Annual Congress 2009 - PG5 Core Curriculum Postgraduate Course: Obstructive sleep apnoea – current pathophysiological, clinical and therapeutic concepts Year: 2009
Measures of nocturnal oxyhemoglobin desaturation in children with obstructive lung disease or sleep-disordered breathing Source: International Congress 2018 – Improvements in the assessment of paediatric physiology Year: 2018
Cardiovascular morbidity and obstructive sleep apnoea in children Source: Annual Congress 2009 - Current developments in sleep-disordered breathing in children Year: 2009
Role of CPAP treatment in elderly with moderate obstructive sleep apnea Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019
Cardiovascular and metabolic consequences of obstructive sleep apnoea Source: Eur Respir J 2001; 18: Suppl. 33, 519s Year: 2001
Predictors of long-term PAP-adherence in obstructive sleep apnea syndrome Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012